GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GN10564 structure
    GN10564Ecdysterone
    CAS: 5289-74-7
    Purity: >99.50%

    Ecdysterone est une ecdysone naturelle qui contrôle la mue (la formation de plumes) et la métamorphose dans les arthropodes.

  • GN10566 structure
    GN10566Gypenoside XVII
    CAS: 80321-69-3
    Purity: >98.00%

    Gypenoside XVII est une nouvelle phytoestrogène isolée principalement à partir des plantes Gynostemma pentaphyllum et Panax notoginseng, il réduit de manière dose-dépendante la libération de glutamate, sa valeur d'IC50 est 16μM.

  • GN10567 structure
    GN10567Z-Ligustilide
    CAS: 81944-09-4
    Purity: >98.00%
  • GN10568 structure
    GN10568Isosilybin
    CAS: 72581-71-6
    Purity: >98.00%
  • GN10569 structure
    GN10569Lobetyolin
    CAS: 136085-37-5
    Purity: >98.00%

    Lobetyolin est un dérivé du lobetyol substitué par un glucopyranose.

  • GN10577 structure
    GN10577Coptisine chloride
    CAS: 6020-18-4
    Purity: >98.00%
  • GN10578 structure
    GN10578Polygalacic acid
    CAS: 22338-71-2
    Purity: >98.50%
  • GN10579 structure
    GN10579Aristolochic Acid A
    CAS: 313-67-7
    Purity: >99.50%
  • GN10582 structure
    GN10582Liquiritin
    CAS: 551-15-5
    Purity: >98.00%
  • GN10583 structure
    GN10583Dihydromyricetin
    CAS: 27200-12-0
    Purity: >98.00%

    Dihydromyricetin est un flavanonol naturel isolé d' A. grossedentata et H. dulcis qui possède des propriétés anti-oxydantes, anti-prolifératives et anti-intoxication alcoolique.

  • GN10584 structure
    GN10584Ginsenoside Rk1
    CAS: 494753-69-4
    Purity: >98.00%
  • GN10585 structure
    GN10585Tetramethylpyrazine
    CAS: 1124-11-4
    Purity: >99.50%

    Tetramethylpyrazine est un alcaloïde isolé du rhizome de Chuanxiong, qui présente des activités anti-inflammatoires, antioxydantes, antitumorales, de régulation de l'autophagie, de vasodilatation, de régulation de l'angiogenèse, d'inhibition des lésions mitochondriaux, de protection endothéliale et de neuroprotection.

  • GN10590 structure
    GN10590Bakuchiol
    CAS: 10309-37-2
    Purity: >98.00%
  • GN10592 structure
    GN10592Platycodin D
    CAS: 58479-68-8
    Purity: >98.00%
  • GN10599 structure
    GN10599Procyanidin B2
    CAS: 29106-49-8
    Purity: >98.00%

    Procyanidin B2 (PB2), un antioxydant à partir du groupe des polyphénols flavonoïdes proanthocyanidines, est trouvé dans les plantes comme les graines de raisin, les baies, le cacao et le thé, offre les avantages pharmacologiques tels que les effets antioxydants et anti-inflammatoires.

  • GN10603 structure
    GN10603Sennoside B
    CAS: 128-57-4
    Purity: >99.00%
  • GN10605 structure
    GN10605(+)-Catechin hydrate
    CAS: 225937-10-0
    Purity: >99.50%
  • GN10606 structure
    GN10606Yohimbine Hydrochloride
    CAS: 65-19-0
    Purity: >98.00%

    Yohimbine Hydrochloride est un antagoniste naturel des récepteurs α2-adrénergiques, actif par voie orale.

  • GN10607 structure
    GN10607Nuciferine
    CAS: 475-83-2
    Purity: >98.00%

    Nuciferine, un principal composant bioactif issu de la feuille de lotus, est un antagoniste des récepteurs 5-HT 2A , 5-HT 2C et 5-HT 2B avec des valeur d' IC 50 respectives de 0.478μM, 0.131μM et 1μM.

  • GN10609 structure
    GN10609Coptisine Sulfate
    CAS: 1198398-71-8
    Purity: >98.00%
  • GN10612 structure
    GN10612(+)- Praeruptorin C
    CAS: 72463-77-5
    Purity: >98.00%
  • GN10613 structure
    GN10613Hesperidin
    CAS: 520-26-3
    Purity: >99.00%

    Hesperidin, un flavonoïde provenant de la peau de l'orange navel, inhibe la peroxydation lipidique, sa valeur d'IC50 est 179,1μM.

  • GN10614 structure
    GN10614Ginsenoside Rg2
    CAS: 52286-74-5
    Purity: >98.00%
  • GN10616 structure
    GN10616Timosaponin AIII
    CAS: 41059-79-4
    Purity: >98.00%

    Timosaponin AIII inhibe l'activité de l'acétylcholinestérase (AChE), sa valeur d'IC50 est 35,4μM.